4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000950170-23-031775
Options or other derivatives
- Director acquired 22,137 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Walker Neal Director | 2023-06-30 | Grant or award · Stock Option (Right to Buy) | +21,222 | 21,222 | D | ||
| Walker Neal Director | 2023-06-30 | Grant or award · Stock Option (Right to Buy) | +915 | 915 | D | ||
Loading xslF345X04/ownership.xml…